- Home
- IRS vs CRMD Comparison
IRS vs CRMD Comparison
Compare IRS & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRS
- CRMD
- Stock Information
- Founded
- IRS 1943
- CRMD 2006
- Country
- IRS Argentina
- CRMD United States
- Employees
- IRS N/A
- CRMD N/A
- Industry
- IRS Homebuilding
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- IRS Real Estate
- CRMD Health Care
- Exchange
- IRS Nasdaq
- CRMD Nasdaq
- Market Cap
- IRS 1.1B
- CRMD 877.5M
- IPO Year
- IRS 1994
- CRMD 2010
- Fundamental
- Price
- IRS $15.60
- CRMD $11.49
- Analyst Decision
- IRS Strong Buy
- CRMD Strong Buy
- Analyst Count
- IRS 1
- CRMD 7
- Target Price
- IRS $12.62
- CRMD $17.33
- AVG Volume (30 Days)
- IRS 173.8K
- CRMD 2.3M
- Earning Date
- IRS 09-02-2025
- CRMD 08-13-2025
- Dividend Yield
- IRS 6.40%
- CRMD N/A
- EPS Growth
- IRS N/A
- CRMD N/A
- EPS
- IRS 0.20
- CRMD 0.28
- Revenue
- IRS $308,539,877.00
- CRMD $82,553,827.00
- Revenue This Year
- IRS N/A
- CRMD $278.96
- Revenue Next Year
- IRS N/A
- CRMD $45.85
- P/E Ratio
- IRS $7.03
- CRMD $41.39
- Revenue Growth
- IRS N/A
- CRMD N/A
- 52 Week Low
- IRS $7.93
- CRMD $3.61
- 52 Week High
- IRS $17.67
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- IRS 65.19
- CRMD 44.95
- Support Level
- IRS $14.29
- CRMD $10.70
- Resistance Level
- IRS $15.07
- CRMD $11.92
- Average True Range (ATR)
- IRS 0.47
- CRMD 0.44
- MACD
- IRS 0.12
- CRMD 0.03
- Stochastic Oscillator
- IRS 98.66
- CRMD 64.75
About IRS IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segment includes Shopping Malls; Offices; Sales and Developments; Hotels and others. It generates maximum revenue from the Shopping Malls segment. The Shopping Malls segment comprised of lease and service revenues related to rental of commercial space and other spaces in the shopping malls of the company.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.